Polymorphisms in the 5α-Reductase Type 2 Gene and Response to Finasteride Treatment in BPH

    April 2006 in “ The Journal of Urology
    Falke Schmidt, Matthias D. Hofer, Alexandre de la Taille, A. Descazeaud, Mark A. Rubin
    New to Finasteride? There is a guide in the encyclopedia. Read the guide →
    Studysummary This study investigates the potential influence of genetic variations in the 5α-reductase type 2 gene on the effectiveness of finasteride treatment for benign prostatic hyperplasia, but it reports no new clinical results.
    Our plain-language summary. Not medical advice or a treatment recommendation. Consult a qualified healthcare professional before changing treatment. Full disclaimer
    Discuss this study in the Community →